Functional Inactivation of pRb Associated with Cyclin D1- and Cyclin-dependent Kinase 4 Overexpression Plays A Key Role in Human Pituitary Tumorigenesis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Human pituitary adenoma (PA) is a common intracranial tumor, but the mechanism underlying tumorigenesis has not been established. Functional inactivation of retinoblastoma protein (pRb) following cyclin D1- and cyclin-dependent kinase (CDK) 4-dependent hyperphosphorylation is one of the most important mechanisms in tumor cell proliferation. We evaluated immunohistochemical expressions of cyclin D1, CDK4 and phosphorylated pRb (p-pRb) in 50 PAs to investigate a role for functional inactivation of pRb associated with cyclin D1/CDK4 overexpression in pituitary tumorigenesis and to correlate it with clinicopathologic variables. Methods : Fifty human PAs were immunohistochemically stained for cyclin D1, CDK4 and p-pRb (Thr 356). Correlations between their expression and the clinicopathologic characteristics were statistically analyzed. Results : Cyclin D1 and CDK4 were overexpressed in 56% and 64%, respectively; pRb was hyperphosphorylated in 64%. Forty one cases (82%) showed one or more of these altered expressions. Overexpressions of cyclin D1 and CDK4 were correlated with functional pRb inactivation. Cyclin D1 overexpression was associated with apoplexy and growth hormone production. Conclusions : Functional inactivation of pRb associated with the cyclin D1/CDK4 overexpression might play a key role in human pituitary tumorigenesis. CDK4 worked in concert with cyclin D1 to hyperphosphorylate pRb. Pituitary apoplexy appeared to be associated with cyclin D1 overexpression.
Abstract
Background : Human pituitary adenoma (PA) is a common intracranial tumor, but the mechanism underlying tumorigenesis has not been established. Functional inactivation of retinoblastoma protein (pRb) following cyclin D1- and cyclin-dependent kinase (CDK) 4-dependent hyperphosphorylation is one of the most important mechanisms in tumor cell proliferation. We evaluated immunohistochemical expressions of cyclin D1, CDK4 and phosphorylated pRb (p-pRb) in 50 PAs to investigate a role for functional inactivation of pRb associated with cyclin D1/CDK4 overexpression in pituitary tumorigenesis and to correlate it with clinicopathologic variables. Methods : Fifty human PAs were immunohistochemically stained for cyclin D1, CDK4 and p-pRb (Thr 356). Correlations between their expression and the clinicopathologic characteristics were statistically analyzed. Results : Cyclin D1 and CDK4 were overexpressed in 56% and 64%, respectively; pRb was hyperphosphorylated in 64%. Forty one cases (82%) showed one or more of these altered expressions. Overexpressions of cyclin D1 and CDK4 were correlated with functional pRb inactivation. Cyclin D1 overexpression was associated with apoplexy and growth hormone production. Conclusions : Functional inactivation of pRb associated with the cyclin D1/CDK4 overexpression might play a key role in human pituitary tumorigenesis. CDK4 worked in concert with cyclin D1 to hyperphosphorylate pRb. Pituitary apoplexy appeared to be associated with cyclin D1 overexpression.
참고문헌 (24)
- Asa SL, "The cytogenesis and pathogenesis of pituitary adenomas", Endocr Rev, 19, pp.798~827 (1998)
- Simpson DJ, "Aberrant expression of G1", S regulators is a frequent event in sporadic pituitary adenomas, 2001, pp.22, 1149~1154
- Ogino A, "The p15INK4b", p16INK4a, J Neuropathol Exp Neurol, pp.2005, 64[DOI]
- Hibberts NA, "Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors", Clin Cancer Res, 5, pp.2133~2139 (1999)
- Farrell WE, "Molecular genesis of pituitary tumors", Frontiers in Neuropathol, 21, pp.174~198 (2000)
- Jordan S, "Cyclin D and cyclin E expression in normal and adenomatous pituitary", Eur J Endocrinol, 143, pp.R1~R6 (2000)
- Cryns V, "The retinoblastoma gene in human pituitary tumors", J Clin Endocrinol Metab, 77, pp.644~646 (1993)
- Bates AS, "Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker", J Clin Endocrinol Metab, 82, pp.818~824 (1997)
- Woloschak M, "Abundance and state of phosphorylation of the retinoblastoma gene product in human pituitary tumors", Int J Cancer, 67, pp.16~19 (1996)
- Simpson DJ, "Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas", Cancer Res, 59, pp.1562~1566 (1999)
- Dowdy SF, "Physical interaction of the retinoblastoma protein with human D cyclins", Cell, 73, pp.499~511 (1993)
- Serrano M, "Role of the INK4A locus in tumor suppression and cell mortality", Cell, 85, pp.27~37 (1996)
- Sherr CJ, "D type cyclins", Trends Biochem Sci, 20, pp.187~190 (1995)
- Connell-Crowley L, "Cyclin D1", Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by sitespecific phosphorylation, 1997, pp.8, 287~301
- Knudsen ES, "Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation", Mol Cell Biol, 17, pp.5771~5783 (1997)
- Roesch A, "Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma", Mod Pathol, 18, pp.565~572 (2005)
- Hardy J, "Transsphenoidal microsurgical treatment of pituitary tumours. in: Recent advances in the diagnosis and treatment of pituitary tumours", pp.375~388 (1979), Raven Press
- Betticher DC, "G1 control gene status is frequently altered in resectable non-small cell lung cancer", Int J Cancer, 74, pp.556~562 (1997)
- Roncalli M, "Cell cycle related gene abnormalities and product expression in oesophageal carcinoma", Lab Invest, 78, pp.1049~1057 (1998)
- Palmero I, "Perturbation of cell cycle regulators in human cancer", Cancer Surv, 27, pp.351~367 (1996)
- Asa SL, "The cytogenesis and pathogenesis of pituitary ade nomas", Endocr Rev, 19, pp.798~827 (1998)
- Sherr CJ, "Cancer cell cycles", Science, 274, pp.1672~1677 (1996)
- Betticher DC, "Prognostic significance of CCND1 (cyclin D1) overexpression in primary non-small cell lung cancer", Br J Cancer, 73, pp.294~300 (1996)
- Pei L, "Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB", Cancer Res, 55, pp.1613~1616 (1995)